These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 25269472

  • 1. p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system.
    Xia M, Yu H, Gu S, Xu Y, Su J, Li H, Kang J, Cui M.
    Int J Oncol; 2014 Dec; 45(6):2341-8. PubMed ID: 25269472
    [Abstract] [Full Text] [Related]

  • 2. p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins.
    Yu H, Su J, Xu Y, Kang J, Li H, Zhang L, Yi H, Xiang X, Liu F, Sun L.
    Eur J Cancer; 2011 Jul; 47(10):1585-94. PubMed ID: 21371883
    [Abstract] [Full Text] [Related]

  • 3. p62/SQSTM1 protects against cisplatin-induced oxidative stress in kidneys by mediating the cross talk between autophagy and the Keap1-Nrf2 signalling pathway.
    Liao W, Wang Z, Fu Z, Ma H, Jiang M, Xu A, Zhang W.
    Free Radic Res; 2019 Jul; 53(7):800-814. PubMed ID: 31223046
    [Abstract] [Full Text] [Related]

  • 4. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.
    van Jaarsveld MT, Helleman J, Boersma AW, van Kuijk PF, van Ijcken WF, Despierre E, Vergote I, Mathijssen RH, Berns EM, Verweij J, Pothof J, Wiemer EA.
    Oncogene; 2013 Sep 05; 32(36):4284-93. PubMed ID: 23045278
    [Abstract] [Full Text] [Related]

  • 5. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription.
    Jain A, Lamark T, Sjøttem E, Larsen KB, Awuh JA, Øvervatn A, McMahon M, Hayes JD, Johansen T.
    J Biol Chem; 2010 Jul 16; 285(29):22576-91. PubMed ID: 20452972
    [Abstract] [Full Text] [Related]

  • 6. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL, McCauley L, Trevino I, Wigley WC, Ferguson DA.
    PLoS One; 2015 Jul 16; 10(8):e0135257. PubMed ID: 26301506
    [Abstract] [Full Text] [Related]

  • 7. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
    Gjyshi O, Flaherty S, Veettil MV, Johnson KE, Chandran B, Bottero V.
    J Virol; 2015 Feb 16; 89(4):2268-86. PubMed ID: 25505069
    [Abstract] [Full Text] [Related]

  • 8. p62 at the interface of autophagy, oxidative stress signaling, and cancer.
    Nezis IP, Stenmark H.
    Antioxid Redox Signal; 2012 Sep 01; 17(5):786-93. PubMed ID: 22074114
    [Abstract] [Full Text] [Related]

  • 9. p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.
    Yan XY, Zhang Y, Zhang JJ, Zhang LC, Liu YN, Wu Y, Xue YN, Lu SY, Su J, Sun LK.
    Cancer Sci; 2017 Jul 01; 108(7):1405-1413. PubMed ID: 28498503
    [Abstract] [Full Text] [Related]

  • 10. TAK1 Regulates the Nrf2 Antioxidant System Through Modulating p62/SQSTM1.
    Hashimoto K, Simmons AN, Kajino-Sakamoto R, Tsuji Y, Ninomiya-Tsuji J.
    Antioxid Redox Signal; 2016 Dec 10; 25(17):953-964. PubMed ID: 27245349
    [Abstract] [Full Text] [Related]

  • 11. SPBP is a sulforaphane induced transcriptional coactivator of NRF2 regulating expression of the autophagy receptor p62/SQSTM1.
    Darvekar SR, Elvenes J, Brenne HB, Johansen T, Sjøttem E.
    PLoS One; 2014 Dec 10; 9(1):e85262. PubMed ID: 24416372
    [Abstract] [Full Text] [Related]

  • 12. Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
    Cucci MA, Grattarola M, Dianzani C, Damia G, Ricci F, Roetto A, Trotta F, Barrera G, Pizzimenti S.
    Free Radic Biol Med; 2020 Apr 10; 150():125-135. PubMed ID: 32101771
    [Abstract] [Full Text] [Related]

  • 13. Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.
    Zou W, Ma X, Hua W, Chen B, Cai G.
    Oncol Rep; 2015 Dec 10; 34(6):3256-63. PubMed ID: 26503358
    [Abstract] [Full Text] [Related]

  • 14. Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis.
    Stępkowski TM, Kruszewski MK.
    Free Radic Biol Med; 2011 May 01; 50(9):1186-95. PubMed ID: 21295136
    [Abstract] [Full Text] [Related]

  • 15. Activation of p62-keap1-Nrf2 antioxidant pathway in the early stage of acetaminophen-induced acute liver injury in mice.
    Shen Z, Wang Y, Su Z, Kou R, Xie K, Song F.
    Chem Biol Interact; 2018 Feb 25; 282():22-28. PubMed ID: 29331651
    [Abstract] [Full Text] [Related]

  • 16. Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity.
    Park JS, Kang DH, Lee DH, Bae SH.
    Biochem Biophys Res Commun; 2015 Oct 09; 466(1):131-7. PubMed ID: 26325428
    [Abstract] [Full Text] [Related]

  • 17. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor.
    Katsuragi Y, Ichimura Y, Komatsu M.
    FEBS J; 2015 Dec 09; 282(24):4672-8. PubMed ID: 26432171
    [Abstract] [Full Text] [Related]

  • 18. The role of the catecholic and the electrophilic moieties of caffeic acid in Nrf2/Keap1 pathway activation in ovarian carcinoma cell lines.
    Sirota R, Gibson D, Kohen R.
    Redox Biol; 2015 Dec 09; 4():48-59. PubMed ID: 25498967
    [Abstract] [Full Text] [Related]

  • 19. Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1.
    Shen C, Wang W, Tao L, Liu B, Yang Z, Tao H.
    Int J Mol Med; 2013 Aug 09; 32(2):448-56. PubMed ID: 23722646
    [Abstract] [Full Text] [Related]

  • 20. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T, Ishii Y, Homma S, Morishima Y, Kurishima K, Itoh K, Yamamoto M, Minami Y, Noguchi M, Hizawa N.
    Oncogene; 2012 Nov 08; 31(45):4768-77. PubMed ID: 22249257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.